Advertisement
UK markets closed

  • FTSE 100

    7,895.85
    +18.80 (+0.24%)
     

  • FTSE 250

    19,391.30
    -59.37 (-0.31%)
     

  • AIM

    745.67
    +0.38 (+0.05%)
     

  • GBP/EUR

    1.1611
    -0.0072 (-0.62%)
     

  • GBP/USD

    1.2372
    -0.0067 (-0.54%)
     

  • Bitcoin GBP

    51,980.76
    +744.70 (+1.45%)
     

  • CMC Crypto 200

    1,381.42
    +68.80 (+5.24%)
     

  • S&P 500

    4,968.27
    -42.85 (-0.86%)
     

  • DOW

    37,995.78
    +220.40 (+0.58%)
     

  • CRUDE OIL

    83.20
    +0.47 (+0.57%)
     

  • GOLD FUTURES

    2,402.90
    +4.90 (+0.20%)
     

  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

  • HANG SENG

    16,224.14
    -161.73 (-0.99%)
     

  • DAX

    17,737.36
    -100.04 (-0.56%)
     

  • CAC 40

    8,022.41
    -0.85 (-0.01%)
     
Property:

11 beautiful homes with glorious garden rooms

Investing in a home with a garden room will enable you to enjoy your outside space whatever the weather

Global Membrane Oxygenators Market Report 2021: Growing Prevalence of COVID-19, Respiratory Failures and Cardiopulmonary Diseases - Forecast to 2028

Research and Markets
·5-min read

Dublin, Aug. 18, 2021 (GLOBE NEWSWIRE) -- The "Membrane Oxygenators Market Size, Share & Trends Analysis Report by Type (Hollow Fiber, Flat Sheet), by Application (Cardiac, Respiratory, ECPR), by Age Group (Neonates, Adults, Pediatrics), by Region, and Segment Forecasts, 2021 - 2028" report has been added to ResearchAndMarkets.com's offering.

The global membrane oxygenators market size is expected to reach USD 141.5 million by 2028, expanding at a CAGR of 1.5%

Key factors expected to boost the market include the growing prevalence of respiratory failures and cardiopulmonary diseases.

Furthermore, there has been a rise in the number of patients suffering from COVID-19 and chronic obstructive pulmonary disease, which can require membrane oxygenators for treatment, enhancing their adoption. Technological advancements in medical devices are expected to further propel their demand in hospitals.

Leading market participants operating in this industry are focusing on developing technologically advanced membrane oxygenators. For instance, in January 2019, Terumo Medical Corporation launched the smallest, lowest prime volume, full-size adult oxygenator-Capiox NX19-with Ultraprime technology.

Significant features of this device are it minimizes inflammatory response and provides higher efficiency microemboli removal. Portable adaptors and compact membrane oxygenators in ECMO circuits have also been developed, which help in the transportation of critically ill patients. The recent developments in medical devices are estimated to drive market growth.

Cardiovascular diseases are among the leading causes of death across the globe. As per the WHO, in 2016, around 17.9 million CVD-related deaths were reported globally. A membrane oxygenator is used to treat patients with cardiac and respiratory diseases.

ADVERTISEMENT

ECMO machine removes carbon dioxide and delivers oxygen in patients when the lungs and heart fail to carry out the process of blood oxygenation. Hence, the rising occurrence of cardiac and respiratory disorders is anticipated to create robust growth opportunities.

Membrane Oxygenators Market Report Highlights

  • North America accounted for the largest revenue share in 2020 owing to the growing innovation in healthcare technologies, reducing healthcare expenditure, and increasing demand for membrane oxygenator devices in hospitals

  • By type, the hollow fiber membrane oxygenator segment accounted for the largest revenue share in 2020, as they offer support after cardiac shock as a fast response system

  • By application, the cardiac segment is expected to grow at an exponential rate over the forecast period, due to the increasing incidence of cardiac conditions such as cardiac arrest and myocardial infarction

  • The neonates segment held a significant market share in 2020, due to increasing incidence of acute respiratory distress syndrome, congenital diaphragmatic hernia, air leak syndrome, respiratory failure, persistent pulmonary hypertension, and pneumonia

  • The key companies focus on new product launches, strategic acquisitions, and mergers to attain a larger market share

Key Topics Covered:

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Research Methodology
1.3. Information Procurement
1.4. Information or Data Analysis

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. Application outlook
2.2.3. Age group outlook
2.2.4. Regional outlook
2.3. Competitive Insights

Chapter 3. Membrane Oxygenator Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Increasing prevalence of cardiopulmonary and respiratory diseases
3.4.1.2. Boosting adoption of membrane oxygenator
3.4.1.3. Technological advancements
3.4.1.4. Expanding applications
3.4.2. Market restraint analysis
3.4.2.1. Complications associated with membrane oxygenator treatment
3.4.2.2. Availability of conventional techniques
3.5. Membrane Oxygenator Market Analysis Tools
3.5.1. Industry analysis - Porter's
3.5.2. PESTEL analysis

Chapter 4. Membrane Oxygenator Market: By Type Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Hollow fiber membrane oxygenator
4.1.2. Flat sheet membrane oxygenators
4.2. Type Market Share, 2021 & 2028
4.3. Segment Dashboard
4.4. Global Membrane Oxygenator Market, by Type Outlook
4.4.1. Hollow fiber membrane oxygenators
4.4.2. Flat sheet membrane oxygenators

Chapter 5. Membrane Oxygenator Market: By Application Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Respiratory
5.1.2. Cardiac
5.1.3. ECPR
5.2. Application Market Share, 2021 & 2028
5.3. Segment Dashboard
5.4. Global Membrane Oxygenator Market, by Application Outlook
5.4.1. Respiratory
5.4.1.1. Respiratory market estimates and forecast, 2016 - 2028 (USD Million)
5.4.1.2. Respiratory failure
5.4.1.3. Pulmonary embolism
5.4.1.3.1. Pulmonary embolism market estimates and forecast, 2016 - 2028 (USD Million)
5.4.1.3.2. Acute respiratory distress syndrome
5.4.1.4. Pneumonia
5.4.1.5. COVID-19
5.4.2. Cardiac
5.4.2.2. Acute myocardial infarction
5.4.2.3. Myocarditis
5.4.2.4. Post-transplant complications
5.4.2.5. Decompensated cardiomyopathy
5.4.2.6. Cardiogenic shock
5.4.3. ECPR

Chapter 6. Membrane Oxygenator Market: By Age group Estimates & Trend Analysis
6.1. Definitions and Scope
6.1.1. Adults
6.1.2. Neonates
6.1.3. Pediatrics
6.2. By Age group Market Share, 2021 & 2028
6.3. Segment Dashboard
6.4. Global Membrane Oxygenator Market by Age group Outlook
6.4.1. Adults
6.4.2. Neonates
6.4.3. Pediatrics

Chapter 7. Membrane Oxygenator Market: Country Estimates & Trend Analysis
7.1. Country Market Share Analysis, 2021 & 2028
7.2. County Market Dashboard
7.3. Regional Market Snapshot
7.4. Regional Market Share and Leading Players, 2020

Chapter 8. Competitive Landscape

  • Medtronic

  • Fresenius SE & Co KGaA

  • Getinge AB

  • Terumo Medical Corporation

  • Microport Scientific Corporation

  • Nipro Medical Corporation

  • LivaNova PLC

  • Cytosorbents Corporation

For more information about this report visit https://www.researchandmarkets.com/r/a9vwip

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900